Cipla (CIPLA) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves new KMPs and updates contact details

🔄 What Changed
New appointments of Managing Director, CFO, Company Secretary, and General Counsel

💡 Investor Takeaway
Shareholders see leadership continuity with updated contact information.

Cipla announced board approval of key managerial personnel changes effective 24 July 2026, including new Managing Director Achin Gupta, CFO Dinesh Jain, Company Secretary Rajendra Chopra, and General Counsel Meera Vanjari, with updated contact details disclosed under SEBI Regulation 30(5).

2 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approved change in reporting for Sanjay Joseph, Head of API Business.

🔄 What Changed
Sanjay Joseph will cease to be a Senior Management Personnel effective 24 July 2026.

💡 Investor Takeaway
This leadership reporting change may affect API business execution and investor confidence.

Cipla announced that Sanjay Joseph, Head of API Business, will cease to be a Senior Management Personnel effective 24 July 2026 due to a change in reporting, as approved by the Board on 23 July 2026.

3 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves CFO succession with Jain taking over from Adukia

🔄 What Changed
Ashish Adukia ceased as Global CFO and KMP; Dinesh Jain appointed as new Global CFO and KMP effective 24 July 2026

💡 Investor Takeaway
The CFO transition signals stable leadership continuity without dilution or payout changes

Cipla announced board-approved succession in its finance leadership: Ashish Adukia stepped down as Global CFO and KMP effective close of business on 23 July 2026, with Dinesh Jain appointed to the roles from 24 July 2026. The transition was disclosed under SEBI Regulation 30 requirements, with Jain bringing over three decades of experience in corporate finance, M&A, and fundraising. The board meeting concluded at 1:00 p.m. IST after starting at 9:15 a.m.

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"What is the impact of new KMPs on Cipla's strategy?" "How do these appointments affect Cipla's valuation?" "What is the market reaction to these leadership changes?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 23 July 2026

INFY Infosys Limited Financial Results PNBHOUSING PNB Housing Finance Limited Annual Report BPCL Bharat Petroleum Corporation Limited Financial Results CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SONACOMS Sona BLW Precision Forgings Limited Financial Results TRU TruCap Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.